Insula Structure and Function in a Nonhuman Primate Model of Induced Early Alzheimer's Disease
Insula Structure and Function in a Nonhuman Primate Model of Induced Early Alzheimer's Disease
批准号:
10680396
负责人:
Joseph Charbonneau
金额:
$4.04万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2025-07-31
关键词:
AdultAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer’s disease biomarkerAnimal ModelAnimalsAnteriorAutopsyAwarenessBehaviorBehavior assessmentBehavioralBrainCardiacCause of DeathClinicalCognitionCognitiveComplementDataDeteriorationDiagnosisDiseaseDisease MarkerDisease ProgressionEarly InterventionEarly identificationEnvironmentExhibitsFunctional ImagingFunctional Magnetic Resonance ImagingHeterogeneityHistologicHistologyHumanImageImaging TechniquesImmunohistochemistryImpairmentInsula of ReilInteroceptionInterventionIntraventricularInvestigationKnowledgeLearningMacaca mulattaMagnetic Resonance ImagingMemoryMemory impairmentMentorsMentorshipModelingMonkeysNerve DegenerationNeurobiologyNeurofibrillary TanglesOnset of illnessPathogenesisPathologyPatientsPeptidesPerformancePersonsPhysiologicalPhysiological ProcessesPhysiologyPopulationPrevalencePublic HealthResearchRestSelf PerceptionSenile PlaquesSignal TransductionStimulusStructureSymptomsTechniquesTestingTimeTrainingTranslatingTranslationsUnited StatesWorkabeta oligomeragedbehavior measurementbehavior testcaregiver depressionclinical diagnosticscognitive capacitycomputerizeddensitydesigndiagnostic criteriaeffective interventioneffective therapyexperimental studygray matterheart rhythmin vivoindexinginsightmetacognitionmiddle agemouse modelneuralneural correlateneuropathologynonhuman primatepre-clinicalpsychologicresponsestatisticsstructural imaging
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
One in 10 adults who are aged 65 or older and 1 in 3 adults who are aged 85 or older meet the clinical diagnostic
criteria for Alzheimer’s disease (AD), making AD a public health crisis. These statistics are certain to be
underestimates of the disease’s total impact, given that disease onset precedes symptom onset by many years
in all cases. With no known cure, the prevalence and impact of AD will only become more dire as the population
ages. Effective intervention is contingent on the identification of behavioral and neurobiological markers that
appear in preclinical AD. While most AD research has focused on declines in learning and memory, people with
preclinical AD often have changes to their self-awareness of both physiological and psychological functions prior
to any detectable impairments to learning and memory. Changes to the insular cortex, the putative neural
correlate of self-awareness, have also been characterized in preclinical AD. Behaviors reflective of self-
awareness, and their associated neurobiological substrates, are therefore important potential targets of study
and intervention. The proposed work will characterize these behaviors alongside neurobiological changes in a
highly tractable and translational animal model, where the onset of AD-related neuropathology can be tightly
controlled. We will introduce amyloid beta oligomers (AβOs) into the brains of middle-aged rhesus monkeys—a
manipulation that we have shown causes neuropathology consistent with early AD in humans. In the first aim,
we will assess changes to behavioral indices of self-awareness of physiology (i.e., interoception) and self-
awareness of cognition (i.e., metacognition). In the second aim, we will characterize changes to the structural
integrity and functional connectivity of the insula using magnetic resonance imaging. In the third aim, we will
examine the insula postmortem for known biomarkers of AD pathology. The aims of this proposal have been
designed such that all experiments have direct translation to established behavioral tests and techniques
available for use with human patients. The proposed experiments have also been designed to maximize training
potential in behavioral, imaging, histological, and statistical techniques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Insula Structure and Function in a Nonhuman Primate Model of Induced Early Alzheimer's Disease
-
批准号:10463220
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2022
-
负责人:Joseph Charbonneau
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: